UK Health Authorities Warn Against Fake Botox Injections After Severe Poisoning Cases

British health authorities have issued warnings concerning the dangers of counterfeit Botox injections after several severe poisoning cases were reported, some of which posed life-threatening risks to patients.

The Medicines and Healthcare products Regulatory Agency (MHRA) announced an increase in warnings related to Botox injections due to a notable rise in hospital admissions caused by complications linked to unlicensed products.

Botox is widely used to reduce wrinkles by employing botulinum toxin, which weakens facial muscle movement. However, improper use or counterfeit products can result in botulinum poisoning, a rare condition that causes muscle paralysis and may impair breathing, potentially becoming fatal.

The MHRA stated that warning labels on product packaging and patient information leaflets will be made clearer. They emphasized the importance of recognizing symptoms that may appear within a month after injection, including difficulty swallowing, slurred speech, breathing difficulties, and muscle weakness.

Approximately 900,000 Botox procedures are performed annually in the UK, making it one of the most common cosmetic treatments. Despite this, health authorities caution that the spread of counterfeit products in the market could increase the risk of serious complications.

Among the cases raising concern is that of Kylie Bailey from Peterlee in County Durham. She paid £75 for three anti-wrinkle injections, a price lower than a previous treatment she had undergone.

Days after receiving the injections, Bailey began experiencing sudden vision problems. She told the BBC that she went to Sunderland Royal Hospital, where doctors initially diagnosed her with drooping of the upper eyelid and advised rest before discharging her.

Her condition worsened over the following days, leading to an emergency hospital transfer where she was diagnosed with botulinum poisoning.

Due to the severity of her condition, Bailey spent three days in intensive care and was treated with antitoxin. At one point, her breathing stopped, requiring resuscitation by medical staff.

Bailey later recalled: "I remember lying in bed thinking: I am dying here, and I don’t want to."

She had been injected with "Toxpia," an illegal anti-wrinkle product similar to Botox.

Last year, the UK Health Security Agency (UKHSA) recorded at least 38 cases of botulinum poisoning linked to unlicensed products. Bailey was among 28 cases reported in northeast England, where Durham’s emergency department treated five patients in one night in June, all connected to counterfeit cosmetic injections.

Dr. Alison Cave, Chief Safety Officer at the MHRA, stated that botulinum toxin products can be effective for medical and cosmetic uses when properly administered but warned that serious side effects can occur in rare cases.

She added that patients and healthcare workers should be aware of botulinum poisoning symptoms and respond promptly as it constitutes a medical emergency.